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ABSTRACT OF THE THESIS 
AN ANALYSIS OF EFFICIENCY AND MELT CURVE EFFECTS ON 
QUANTITATIVE POLYMERASE CHAIN REACTION (QPCR) INHIBITION 
by 
Robyn E. Thompson 
Florida International University, 2010 
Miami, Florida 
Professor Bruce McCord, Major Professor 
Real-time or quantitative PCR (qPCR) is an innovative method used to determine 
the amount of amplifiable DNA in a biological sample.  Typically, a fluorescent dye is 
introduced during thermal cycling, causing a change in fluorescent output as the double-
stranded DNA (dsDNA) product accumulates. Both TaqMan® and Plexor HY System 
methods detect PCR inhibition through the monitoring of internal control sequences. 
Alternatively, SYBR®Green and Plexor detect inhibition through melt curve effects.  
Previous work using SYBR®Green intercalation has demonstrated that inhibitors 
can affect melt curves differently depending on their structure and mode of action. 
Inhibitors that bind DNA can cause melt curve shifts while those primarily affecting Taq 
polymerase do not. Unlike SYBR®Green, Plexor dyes are fluorescently linked to a 
modified base, 5'-methylisocytosine (iso-dC), adjacent to the 5' end of the dsDNA. This 
produces minimal interference in dsDNA structure making it an ideal procedure for 
measuring these effects. In this study, inhibition of qPCR was evaluated by observing the 
effects of various inhibitor concentrations and amplicon lengths on DNA amplification.  
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I. INTRODUCTION 
1.1 Brief History of Forensic DNA Analysis 
 Deoxyribonucleic acid (DNA) analysis is a powerful tool for human identity testing 
and is well established in the forensic community. It is used to aid in the identification of 
perpetrators of violent crimes such as murder and rape, in paternity cases and in 
identification of the remains of missing persons. More recently, technological advances 
such as capillary array electrophoresis and real-time polymerase chain reaction have 
become routine in forensic laboratories around the world and standardized protocols have 
been validated for presumptive and confirmatory testing, DNA extraction, DNA 
quantitation and analysis of short tandem repeats (STRs) (Butler, 2005). 
 Although the existence of variable loci in human DNA has been recognized for a 
long period of time, it was not until the late 1970s and early 1980s that use of 
polymorphisms for large-scale mapping of human genes was proposed. Arlene Wyman 
and Ray White established the foundation for this concept, which used a polymorphic 
DNA locus characterized by a variable-length restriction fragments called restriction 
fragment length polymorphisms or RFLP (Wyman et al., 1980). David Botstein et.al later 
initiated the use of RFLP in mapping genes of the human genome to indicate genetic 
differences among individuals (Botstein et al., 1980). However, it was Sir Alec Jeffreys 
who became the first to describe the scientific jargon known today as “DNA 
fingerprinting” or “DNA typing.” Jeffreys, an English geneticist, discovered a set of 
genetic markers called minisatellites or variable number of tandem repeats (VNTRs), 
which are highly specific to an individual (Jeffreys et al., 1985). These VNTRs have 
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highly variable regions of DNA and are composed of targeted tandem sequences repeated 
a number of times within the DNA that could be used to differentiate DNA among 
members of a population. The length of VNTRs ranges from 10-100 base pairs (bp) in 
length, making it highly polymorphic and resulting in a highly discriminating tool for 
human identification. 
 The technique used by Jeffreys to examine VNTRs was RFLP. In RFLP analysis, 
restriction enzymes are used to cut extracted DNA into smaller pieces of 4 to 6 bp 
sequences. The fragments are separated by size using gel electrophoresis and then 
transferred to a nylon membrane by the Southern blot technique. A radioactive probe 
containing a VNTR sequence is hybridized to the single-stranded DNA (ssDNA) attached 
to the nylon membrane for detection (Butler, 2005). The probed DNA is exposed to x-ray 
film, producing a “DNA fingerprint.” Jeffreys proposed the use of HinfI or HaeIII 
restriction enzyme digests with multi-locus (oligonucleotide) probes to detect multiple 
DNA fragments in the human DNA (Jeffreys et al., 1985). The band patterns obtained, 
which are unique to an individual, were difficult to interpret; therefore subsequent 
methods with single locus probes that hybridize to only a specific region of the genome 
were later used.  
 The first court cases in which Jeffreys’ DNA fingerprint methodology was 
successfully used occurred in England during the mid 1980s. These cases involved an 
immigration dispute of a British boy whose parents were originally from Ghana and a 
double rape/homicide of teenage girls in 1985 and 1986, respectively (Jeffreys et al., 
1985; Aronson, 2005).  
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 Another important development was later applied to forensic DNA typing. The 
technology was termed Polymerase Chain Reaction (PCR). The development of PCR in 
1985 by Kary Mullis has lead a great deal of scientific progress in DNA analysis, 
especially in the forensic community. Using the Sanger method, PCR was originally 
developed for DNA sequencing; however, it was later applied to what biologists refer to 
as “Molecular Xeroxing.” This application produces multiple “copies” of a nucleic acid 
sequence in vitro (Mullis, 1990).  
 During the PCR reaction, the double-stranded DNA (dsDNA) undergoes a three-
step process: denaturation, annealing and extension. The strands in each target DNA are 
denatured by heating at high temperatures (~95oC) then cooled to a lower temperature 
(~55oC), allowing the primers (short oligonucleotide sequences) to anneal to the single 
strands. The temperature is then raised (~72°C) and a DNA polymerase enzyme extends 
the primers through incorporation of dinucleotide triphosphates (dNTPs). By doing this, 
synthesis of the dsDNA target is produced in a rapid cyclic process.  For every cycle, 
PCR generates a 2n-fold increase in the target DNA (the amount of DNA theoretically 
doubles). 
 Polymerase chain reaction requires a mixture of reaction components and 
amplification parameters, which must be optimized to produce sufficient amplification 
products.  The major components, included in the “master mix” to be aliquoted into each 
PCR tube are as follows: buffer, dNTPs, polymerase, primers, and magnesium. Thermus 
aquaticus (Taq), a species of bacterium found in hot springs, is the source of the thermal 
stable polymerase used for PCR. The later development of a “hot-start” formulation of 
Taq polymerase, which is inactive until heated (95oC), is another improvement for 
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amplifying samples minimizing the possibility of mispriming and misextension (Butler, 
2005). A modified form of Taq polymerase has been developed named Amplitaq GoldTM 
DNA polymerase (Applied Biosystems, Foster City, CA). Other PCR components that 
may be included are non-acetylated bovine serum albumin (BSA) and dimethylsulfoxide, 
both of which improve the efficiency of the reaction and reduce inhibition.  
 Polymerase chain reaction became an important analytical method for forensic 
samples because of its sensitivity, specificity, rapid analysis, and ease of automation. The 
PCR amplification technology provides the analysis of forensic samples with low 
quantities (<1ng) of extracted DNA, unlike RFLP methods that require at least 50ng 
(Butler, 2005). Additionally, many degraded DNA samples can be amplified and 
subsequently typed because the alleles are much smaller in size compared to the alleles 
detected by RFLP analysis (Mullis et al., 1994; Butler 2003). It provides a valid and 
reliable approach for the analysis of biological evidence found at crime scenes. 
Historically, the first PCR-related approach used for forensic purposes was the detection 
of sequence polymorphisms through the use of allele-specific oligonucleotide (ASO) 
hybridization probes. Approaches involving the detection of PCR amplified length 
polymorphisms known as minisatellites were also explored.  For example the locus 
D1S80 consisted of a 16 base sequence that repeated up to 41 times yielding allele sizes 
400 to greater than 800 bp in length (Duncan et al., 1997). 
 In the late 1980s, during the same time minisatellites were discovered, 
microsatellites – better known as short tandem repeats (STRs) – were being described. 
The STR technology differs from VNTRs by having a shorter repeat sequence (2 to 7 bp) 
and is the primary method presently used in forensic laboratories. Tetramer repeats have 
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become more widely used than loci consisting of di-, tri-, and even penta-nucleotides and 
have been multiplexed with up to sixteen loci co-amplified in a single PCR reaction. 
When compared to other PCR-based methods, STR analysis is faster, more sensitive and 
can be multiplexed, permitting multiple loci to be analyzed in a single run. The STR 
regions are also highly polymorphic, providing an extremely high power of 
discrimination (Butler, 2005). 
 In 1997, the Federal Bureau of Investigation (FBI) Laboratory launched a 
nationwide effort to establish core STR loci for use within a national DNA database 
known as CODIS (Combined DNA Index System) (Budowle, 1999). The thirteen CODIS 
loci are CSF1PO, FGA, TH01, TPOX, VWA, D3S1358, D5S818, D7S820, D8S1179, 
D13S317, D16S539, D18S51 and D21S11. A DNA profile obtained using the thirteen 
autosomal STR loci yields an average random match probability of about one in a trillion 
among randomly chosen individuals (Butler, 2005). These loci are nationally recognized 
as the standard for human identification. Applied Biosystems Foster City, California and 
Promega Corporation in Madison, Wisconsin are the two vendors of multiplex kits that 
include the thirteen core loci for CODIS, AmpFlSTR® Identifiler and PowerPlex®16 
respectively. These manufacturers provide allelic ladders in their multiplex kits as 
standards for accurate genotyping. The kits also contain several additional non-CODIS 
loci as well as a sequence in the Amelogenin gene that contains a 6 bp deletion in the X 
chromosome, permitting its use in sex typing (Sullivan et al., 1993). Overall, this set of 
STR loci is more than adequate for addressing most problems of human identification. 
Due to their high level of polymorphism and discrete allele sizes, the kits are particularly 
useful in resolving DNA mixtures (Parson et al., 2008).  
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 Genetic analyzers, using the capillary gel electrophoresis based technology, are the 
most popular system for separating STR alleles. The foundation of a basic capillary 
electrophoresis device includes a narrow capillary, two vials filed with buffer, and two 
electrodes connected to high voltage power supply (Figure 1-1). For DNA separation, a 
PCR product is injected into a polymer filled capillary. The polymer acts as a sieve to 
separate DNA fragments by charge to size ratio as they move down the capillary under 
the influence of an electric field (Altria, 1995). The smaller negatively charged amplicons 
interact less with the sieving polymers and are therefore detected earlier by a laser-
induced fluorescence detector. Capillary electrophoresis involves a laser that excites the 
fluorescently labeled primers incorporated in the DNA strand, which can be distinguished 
by an emission spectrum with the use of a charged coupled device (CCD) camera (Butler, 
2005). Modern instruments can simultaneously detect up to five dyes. The emission  
 
 
Figure 1-1: Schematic of a capillary electrophoresis instrument. The capillary ends and electrodes 
(connected to a high-voltage power supply) are placed in vials of buffer solution. The sample replaces one 
of the buffers and is introduced into the capillary. When an electric current is passed across the capillary, 
analytes are separated based on mass to charge ratio and detected by a UV or fluorometric detector.  
 7
 
 
 
 
Figure 1-2: Electropherogram of the genetic information of an individual using the Powerplex 16 allelic 
ladder. The colors represent the different fluorescent dyes for each particular locus: Fluorescein (blue), JOE 
(green), TMR (black but represents yellow). CXR (red) shows fragments of the Internal Lane Standard 
(ILS) 600.  The boxed numbers represent the allele calls for each locus. The scales at the top of the peaks 
represent the number of basepairs and the scale to the right represent the intensity of the fluorescent signal 
in relative fluorescent units (RFUs).  
 
 
spectra of these dyes permit multiplexing with allele identification based on size and 
fluorescent wavelength. The data are represented in the form of an electropherogram, 
where each peaks represent the different alleles at a particular locus (Figure 1-2). 
 Commercial multiplex STR kits include allelic ladders, which contain the most 
commonly known alleles for a particular locus, internal sizing standards that are added to 
each sample and a calibrated curve that is established using the known sizes of the 
internal size standard. The amplified alleles are then called and compared to the allelic 
ladder in order to determine the genotype. This is done through the use of software 
programs that are compatible with the modern genetic analyzers. The two programs 
Genescan® and Genotyper® software (Applied Biosystems, Foster City, CA) are used to 
size the PCR products and assign the allele calls respectively. A new software was later 
developed by Applied Biosystems, which merged the two programs known as 
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Genemapper® ID (Butler, 2005).  
 In spite of the advantages associated with STR analysis, there are several 
drawbacks. Short tandem repeats have a lower discrimination power per locus than 
VNTRs because there are a smaller number of alleles and less heterozygosity per locus. 
Interpretation of results may be difficult due to “stutter,” an artifact of the PCR process 
that produces “false” alleles one repeat shorter than the main allele. Another issue occurs 
when alleles contain incomplete repeat units, known as microvariant alleles, resulting in 
small variations in allele size. Similarly, mutations in the flanking regions of template 
DNA can result in poor binding of the primer to the DNA. These situations in which an 
allele may amplify poorly or not at all produces poor peak balance or allele dropout at 
heterozygous loci.  
 Currently the manufacturers continue to upgrade their already validated and highly 
discriminatory STR systems to tolerate samples that have been highly degraded and 
inhibited in order to generate profiles that could not be previously amplified. Such 
systems include PowerPlex 16 Hot-Start (HS) (Promega Corporation, Madison WI) 
(Promega, 2009 (b)), which is more robust and sensitive, generating profiles from as low 
as 100pg of DNA.   
 A relatively recent technological development in forensic DNA typing is 
quantitative PCR (qPCR), also known as real-time PCR. This process involves 
instrumentation that measures the concentration of DNA during PCR as the template is 
amplified. Quantitative PCR uses the same steps as traditional PCR (denaturation, 
annealing, and extension); however a fluorescent marker or probe is introduced in the 
reaction that is sensitive to the formation of dsDNA permitting the measurement of 
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accumulation of amplified products. The primary advantages of DNA quantification by 
qPCR include a wide dynamic range, high-throughput capabilities, high sensitivity and 
target-specific quantitation (Butler, 2005). It is now widely used in forensics, 
predominantly using TaqMan®, SYBR® Green and Plexor HY System real-time 
chemistries (a detailed discussion of this will be presented in Chapter 2).  
 Quantitative PCR and STRs are state-of-the art technologies and are currently the 
methods of choice for quantifying and genotyping forensic samples.  However, there are 
issues such as sample degradation and inhibition due to environmental insults and 
postmortem aging that can prevent successful analysis of samples.  
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II. QUANTITATIVE POLYMERASE CHAIN REACTION (qPCR) 
2.1 Introduction  
 Quantitative PCR was first developed in 1993 by constructing a system that detects 
PCR products as they accumulate (Higuchi et al., 1993). Initially, this “real-time” system 
included an ethidium bromide intercalating dye incorporated into the DNA during 
amplification, a modified thermal cycler with ultraviolet (UV) light source to illuminate 
the samples, and detection of raw fluorescence output from a CCD-camera. 
Amplification produces increasing amounts of dsDNA that bind ethidium bromide, 
therefore increasing the intensity of the fluorescent signal as more copies of DNA are 
produced. The system then plots the relative fluorescence units (RFU) on the y-axis 
versus cycle number on the x-axis. 
 Quantitative PCR can be divided into three distinct phases: exponential (geometric) 
amplification, linear amplification and the plateau region (Bloch et al., 1991) (Figure 2-
1). During the exponential phase of the PCR process, the reaction results in a theoretical 
doubling of amplicons with each cycle.  While the ideal efficiency is not achieved, the 
doubling is close to 100%, yielding a consistent relationship of input DNA to the amount 
of product. At the beginning of the exponential phase, the baseline establishes the 
threshold and occurs when the fluorescence signal is consistent with the normal 
background levels. During the amplification process of a sample, the point at which the 
level of fluorescence exceeds the threshold is referred to as the cycle threshold (CT). The 
CT value is inversely related to the template concentration at the beginning of the qPCR 
process, therefore it is lower for a sample with a higher initial concentration and is higher 
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for a lower concentration sample  (Wilhelm et al., 2000). The CT values of the samples 
are then compared to the standard curve in order to determine the starting concentration. 
The CT values are determined by a linear relationship between the log of the 
concentration of DNA template and the number of PCR cycles (Butler, 2005). During the 
linear phase, the consumption of some of the PCR reagents, such as dNTPs, primers and 
Taq polymerase, will impede the efficiency because they are consumed at different rates. 
For this reason, this phase is not useful for data comparison. As product increases, there 
is a depletion of critical reagents, resulting in the gradual decline in the rate of formation 
of new product. Eventually, PCR enters the plateau phase and the product concentration 
remains constant. 
 
 
 
Figure 2-1: The PCR amplification curve can be broken into three different phases showing the 
accumulation of fluorescent signal at each cycle. Exponential amplification results when there is a 2-fold 
increase in DNA at every cycle. Linear amplification occurs as the reaction components are being 
consumed and eventually become limited. A plateau is reached and the reaction has stopped once no more 
product is made. The graph plots intensity of fluorescence as PCR product accumulates versus the number 
of cycles. 
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2.2 Detection Chemistries 
 There are different approaches that can be used for fluorescence-based detection 
assays including fluorogenic probes, DNA binding dyes, scorpion probes, and molecular 
beacon technology (Bustin, 2000). The two most common methods used are the 
fluorogenic 5nuclease assay – more familiarly known as TaqMan – and SYBR Green 
intercalation. The result of these assays is an increase in fluorescence intensity 
proportional to the amount of amplicon produced.  
 The TaqMan technology is based upon measuring a change in fluorescence due to 
the displacement of a dual dye labeled probe within a target region. The two dyes consist 
of a fluorescence reporter with a quencher dye in close proximity to prevent fluorescence. 
During primer annealing, the probe binds to the sequence and as the Taq extends, its 5' 
exonuclease activity results in degradation of the probe, releasing both of the dyes, thus 
removing the quenching effect and producing fluorescence (Bustin, 2000). Non-specific 
amplification as a result of mis-priming or primer dimerization (primer dimers) does not 
generate fluorescent signal because specific hybridization between the probe and target 
DNA is required. 
 The SYBR Green assay detects formation of all PCR products by dye intercalation. 
Since the dye binds specifically to dsDNA molecules, the real-time fluorescence detector 
can monitor product accumulation during annealing and extension steps. For forensic 
DNA analysis, the most common SYBR Green assay targets human specific Alu 
sequences, which is highly repetitive, has a high degree of sensitivity as well as a wide 
dynamic range, generally 1pg/ul to 10ng/ul DNA standards (Nicklas et al., 2003). Careful 
optimization of the PCR reaction is necessary for specificity since these types of dyes 
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bind to all dsDNA (Morrison et al., 1998). High concentrations of SYBR Green can 
inhibit amplification, therefore limited amounts should be used. 
Recently, a new technique has been developed known as the Plexor HY System, 
which involves the incorporation of a fluorescence quencher into the product during 
amplification. Plexor primers are labeled with a fluorescent dye that is quenched upon 
binding to the previously labeled product. The quenching process (Figure 2-2) can be 
used to measure product accumulation during PCR amplification of dsDNA. The Plexor 
technology permits multiplexing of qPCR as a series of dye labels and quenchers can be 
used. Standard curves are generated using DNA standards in the range of 3.2pg/ul to 
50ng/ul. Table 1-1 displays a comparison of Plexor HY, TaqMan and SYBR Green 
chemistries. 
 The Plexor HY System uses the interaction between two manufactured nucleotides, 
isoguanine (iso-dG) and 5'-methylisocytosine (iso-dC), for qPCR analysis. They form a 
unique base pair when incorporated into the dsDNA and pair only with each other 
(Johnson et al., 2004) (Figure 2-3). The reaction only uses two primers, one containing 
the fluorescent label on the 5' end, adjacent to the modified base, 5'-methylisocytosine 
(iso-dC), and the other unlabelled. The fluorescent quencher (dabcyl) and the modified 
nucleotide, iso-deoxyguanine triphosphate (iso-dGTP), are included in the reaction mix. 
During amplification, the incorporation of dabcyl and iso-dGTP is preferentially at a 
position complimentary only to iso-dC. After subsequent rounds of PCR, the quencher 
and the fluorescent label are sufficiently close together, causing a reduction in the 
fluorescent signal (Frackman et al., 2005) (Figure 2-4). 
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Figure 2-2: Comparison of SYBR Green (and also applies to TaqMan) (green/top) and Plexor HY 
(blue/bottom) amplification curves. For SYBR Green and TaqMan, fluorescence increase in proportion to 
the amount of amplified product, whereas for Plexor, fluorescence decreases as amplification increases. 
 
 Commercial qPCR kits such as the Quantifiler Duo DNA Quantification Kit 
(Applied Biosystems, Foster City CA) and Plexor HY System (Promega Corporation, 
Madison WI) are currently being used and validated to produce robust, reliable and 
reproducible results (LaSalle, 2009). These advantages are important for providing an 
efficient approach to DNA typing. The commercial kits include an internal PCR control 
(IPC) that verifies the amplification process and permits discrimination between low 
template levels and PCR inhibition (Bessetti, 2007).  
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Figure 2-3: Plexor novel basepair. Isoguanine (iso-dG) paired with 5'-methylisocytosine (iso-dC) on left 
and deoxyguanosine paired with deoxycytidine on right (Frackman et al., 2005). 
   
 
 
Figure 2-4: Overview of the Plexor HY Technology for qPCR. The procedure is based upon the 
incorporation of the iso-dC and a fluorescent dye (reporter) during thermal cycling. Throughout the PCR 
process iso-dGTP, bound to a quencher molecule, is incorporated into the new DNA strand opposite the 
iso-dC. In close proximity, the quencher and the reporter cause quenching of fluorescence as DNA product 
accumulates. 
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2.3 Melt Curve Analysis 
 The Watson and Crick double helix structure of a DNA molecule consists of two 
anti-parallel strands that are linked together through a process known as hybridization, 
where nucleotides pair up through the formation of hydrogen bonding between 
complementary bases (Butler, 2005). In Chargaff’s base pairing rule, it states that adenine 
(A) forms a basepair with thymine (T) and guanine (G) forms a basepair with cytosine 
(C), which therefore means that the percentage of bases in DNA should be equal for A 
and T as well as G and C (Chargaff, 1951). Two hydrogen bonds are formed between AT 
basepairs and three hydrogen bonds between GC basepairs. Therefore more energy is 
required to break GC bonds and they have a higher thermal stability than AT bonds 
(Butler, 2005). A DNA molecule may be rich in AT content at one region and rich in GC 
content at other regions. The molecule would therefore be melted in segments since the 
AT pairs would separate before the GC pairs as the temperature is gradually increased.  
The hydrogen bonds linking the DNA strands together can be broken (denatured) 
under various conditions. Denaturation occurs at elevated temperatures or through the 
process of chemical treatment with acidic, alkali, oxidizing, reducing, chelating or 
denaturing agents. The DNA molecule can also be denatured by placing it in a salt 
solution of low ionic strength (Butler 2005).  
 The process of denaturation is reversible. Once a fragment of DNA is exposed to 
high temperatures it will separate into its two strands. However, when the temperature is 
reduced the ssDNA will adhere to its complementary sequence and anneal to each other. 
The process in which the complementary strands re-form to their original conformation is 
known a renaturation (or reannealing).  
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 The melt curve analysis is generally used in conjunction with qPCR. It is generated 
after PCR amplification and indicates a change in fluorescence as temperature is raised 
by a fraction of a degree, from 60oC and slowly increasing to 90oC. Quenched amplicons 
produce a significant change in fluorescent signal as they are denatured. The difference in 
fluorescence is used to determine the melting temperature (Tm), the temperature at which 
amplicon dissociation occurs. The melt curve software plots the rate of change of the 
relative fluorescence units (RFU) with time (T) (-d(RFU)/dT) on the Y-axis versus the 
temperature on the X-axis. The result is a DNA melt curve with a peak signal occurring 
at the Tm. Systems using TaqMan chemistries such as Quantifiler® cannot perform melt 
curve analysis as the formation of dsDNA is monitored in these systems through the use 
of external probes. The Tm of a giver sample is obtained by product length, sequence, GC 
content and strand complementarity (Ririe et al., 1997).  Therefore, nonspecific 
amplification products such as primer-dimer artifacts, mis-priming, and inhibitor binding 
will result in alterations to the melting temperature and curve. The precise shape of the 
curve is also a function of the DNA sequence being melted. This allows amplicons 
containing different length and sequence variants to be discriminated on the basis of melt 
curve shape, irrespective of whether they share the same Tm. 
 Figure 2-5 is a representation of Plexor autosomal melt curves of human DNA for 
different primers generated from the RNU2 sequence (Krenke et al., 2008). The curves 
within the highlighted ± 5oC window indicate the same target DNA, whereas the curves 
outside the window indicate nonspecific amplification.  For the Plexor HY System, the 
Tm of autosomal and IPC amplicons range between 79-81oC and for Y chromosomal 
amplicons, range between 81-83oC (Promega, 2009). 
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 Melt curve analysis can also be used to study high throughput genotyping and 
epigenetic changes in DNA. A technique currently and rapidly being adopted for these 
purposes is high resolution melting (HRM) analysis, which is a relatively new, post-PCR 
analysis method used to identify variations in nucleic acid sequences. Like melt curve 
analysis, HRM is used to characterize samples according to their dissociation behavior as 
they transition from dsDNA to ssDNA with increasing temperature and fluorescence 
detection. Samples can also be discriminated according to their sequence, length, GC 
content or strand complementarity. However, HRM goes beyond the power of traditional 
melt curve analysis by allowing the study of thermal denaturation of dsDNA in much 
more detail, permitting the detection of subtle changes in sequence, GC content or 
structure.  
 Fluorescence intercalating dyes are commonly used in real time PCR melt curve 
analysis. Dyes like SYBR Green are commonly used. These compounds exhibit little it 
binds nonspecifically to the dsDNA. However in the Plexor HY System, the primer that 
 
 
Figure 2-5: Plexor melt curves generated from human DNA for Plexor RNU2 sequence (blue) and newly 
designed RNU2 primer (red) DNA. Differences are due to the presence of nucleotide base content.  
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fluorescence when it is free in solution, but its fluorescence increases significantly when 
contains both the fluorescent label and modified base binds specifically to the 5 end of 
the DNA molecule. Since Plexor HY involves minimal interference in the dsDNA 
structure, it is therefore an ideal procedure for measuring inhibitory effects.  
 
Table 2-1: Comparison of qPCR Detection Chemistries 
 
 
 PLEXOR TAQMAN SYBR GREEN 
Mode  
 
Fluorescence  
quenching 
 
Fluorescence gain 
 
Fluorescence gain 
 
Mechanism 
 
Fluorescent labeled  
primer opposite a  
dabcyl quencher as 
dsDNA forms 
 
5((3( exonuclease 
base degradation of a  
probe quencher pair, 
emitting fluorescence 
when separate 
 
Fluorescent dye  
increases signal 
when intercalated in  
dsDNA 
 
Specificity 
 
Detects specific 
amplification 
products only 
 
Detects specific  
amplification  
products only 
 
Detects all  
amplified dsDNA, 
including non- 
specific reaction  
products 
 
Oligonucleotides 
 
One labeled and one  
unlabeled primer 
 
Two unlabeled  
primers and one 
dual-labeled probe 
 
Two unlabeled  
primers 
 
Melt Curve 
Analysis 
Yes 
 
No 
 
Yes 
 
Multiplex  
Capability 
Yes 
 
Yes 
 
No 
 
IPC Yes 
 
Yes 
 
No 
 
Sensitivity Medium 
 
Low 
 
High 
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2.4 Primer Design 
 Primers are an essential component of the PCR reaction. They contain sequences 
that are the reverse compliment of a specific DNA target. If the primer does not bind 
successfully to the DNA then amplification cannot occur; therefore successful PCR 
entails careful primer design.  There are a number of parameters that should be 
considered when designing primers: primer length, melting temperature (Tm), GC 
content, secondary structures, and product position.  
 The primer length (and annealing temperature) controls the specificity of binding. 
Specificity is defined as the frequency that a mispriming event occurs (Dieffenbach et al., 
1993). The longer the primer sequence, the lower the probability of obtaining another 
sequence other than its target. Primer sequences with long runs of a single base are not 
recommended (Abd-Elsalam, 2003). Generally, primers of 17-25 bp in length work best 
(Robertson et al., 1998). 
 The stability of the primer annealing is measured by its Tm, which is the 
temperature at which 50% of the dsDNA will dissociate and become ssDNA. Optimal Tm 
for primers generally range from 56-62oC (Dieffenbach et al., 1993). Primers with Tm 
above 65oC should also be avoided due to possible secondary annealing (Abd-Elsalam, 
2003). The Tm of the forward and reverse primers should be similar so optimal annealing 
temperatures are close (Robertson et al., 1998). 
 The GC content (GC%) is the percentage of guanidine and cytosine bases in the 
primer and provides information about the strength of annealing. Primers should have a 
GC% between 40-60% (Robertson et al., 1998). The GC content, Tm and annealing 
temperatures are all dependent on one another. For primers with a GC content below 
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50%, the primer length should be extended so that the Tm remains above the minimum 
temperature recommended (Abd-Elsalam, 2003). The GC content for primer pairs should 
also be similar. The difference in GC content can be compensated by altering the length 
of the primer pairs (Robertson et al., 1998). 
 Secondary structures such as hairpins, primer-dimers and self-dimers are formed by 
inter- or intra-molecular forces. The primer can either fold back upon itself or bind to its 
primer pair, which may cause misleading results. Secondary structures are likely to form 
with longer primer lengths (Abd-Elsalam, 2003). 
 The primer can be positioned near the 5' or 3' end of the DNA marker that is to be 
amplified. Usually, sequences close to the 3' end of the marker are preferred for the 
control of mis-priming (Abd-Elsalam, 2003). 
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III. POLYMERASE CHAIN REACTION (PCR) INHIBITION 
3.1 Introduction 
 In addition to the DNA samples being affected due to template degradation, 
contaminants deposited on biological evidence at a crime scene often present a challenge 
in the analysis of DNA in cases of forensic human identification. These source 
contaminants, generally referred to as PCR inhibitors, commingle with DNA samples 
upon exposure to clothing, soils, and other environmental contaminante. Inhibitors can be 
endogenous or exogenous to a PCR reaction (Butler, 2005). Endogenous contaminants 
are process-introduced materials and reagents that are co-extracted with the target DNA 
during the stages of the sample preparation process such as extraction or purification. On 
the other hand, exogenous contaminants originate from improperly controlled hygienic or 
laboratory conditions.  Whatever the source, once present in a biological sample, they can 
co-extract with the DNA and prevent or reduce the sensitivity of PCR amplification. 
 The most common effect of an inhibitor is a decrease in reaction efficiency, 
resulting in either no STR profiles or partial profiles that are difficult to interpret. 
Therefore, it is important for an analyst to know if an inhibitor is present in a DNA 
extract and to take additional steps to remove it prior to PCR amplification. It is also 
important to understand the mechanisms of inhibition so that the analyst can properly 
determine best practices to deal with inhibited samples and interpret results obtained from 
inhibited samples. 
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3.2 Common Polymerase Chain Reaction (PCR) Inhibitors 
 Inhibitors are often present in forensic DNA samples. For casework samples such 
as blood on leaf litter, semen on jeans, or saliva on food items, the inhibitor may 
sometimes be avoided using a transfer method rather than processing a piece of the 
stained material. However, other inhibitors are inherent to biological samples. Common 
inhibitors found in forensic samples are included in various components of bodily fluids 
and tissues (hematin, heparin, collagen, melanin, bile salts, urea), environmental 
compounds (humic, fulvic and tannic acids, phenolic compounds, heavy metals) and food 
constituents (glycogen, fats, calcium ions) (Wilson, 1997). Inhibitors, such as indigo, the 
dye present in denim, may also be extracted with biological material found on clothing. 
Some other examples of endogenous inhibitors include phenol, ethanol, isopropanol, 
ethylenediaminetetraacetic acid (EDTA), potassium chloride (KCl), sodium chloride 
(NaCl) and other salts, guanidinium thiocyanate, and ionic detergents such as sodium 
deoxycholate (SD), and sodium dodecyl sulfate (SDS) (Demeke et al., 2010; Bessetti, 
2007). Exogenous sources include glove powder, bacteria and dust (de Lomas et al., 
1992; Wilson, 1997). Although several inhibitors have been widely reported, eleven of 
these are known to affect forensic samples and were chosen for this particular study (in 
research order):  
 
Calcium  
 Extracted DNA from bone is known to cohere high levels of PCR inhibitors, 
primarily calcium. Calcium is the main inorganic component of bone, which is two-thirds 
of the composition. The other one-third is comprised of organic material. Food samples 
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(Powell et al., 1994; Bickley et al., 1996) and swabs used for DNA isolation (Wadowsky 
et al., 1994) have also been reported as sources of calcium ions for PCR inhibition. 
Calcium is known to be a competitor of magnesium in the PCR reaction as a result of 
their similarity in configuration. This therefore affects the polymerase activity. Very high 
calcium levels can be found in cells, such as 3 to 7 mM in the nucleus of hyperplastic 
prostate epithelial cells (Dobi et al., 1998). Up to 2 mM of calcium may also inhibit 
samples up without the presence of additives of removal procedures (Opel et al., 2010). 
 
Humic Acid 
 Humic acid is one of the major constituents of soil organic matter and consists of a 
mixture of decomposed plant and animal residue (Zipper et al., 2003). It is commonly 
found in aquatic, soil, and sediment environments and is usually encountered in samples 
that have been buried, particularly in those of bone and teeth. Characteristic features 
include its ability to interact with a variety of organic compounds and bind with metal 
ions by complex formation (Zipper et al., 2003; Sutlovic et al., 2008). The 
macromolecular structure of humic acid is primarily aromatic quinonic and heterocyclic 
rings with side chains consisting of polysaccharides, peptide, aliphates, and carboxylic 
acid, carbonyl, alcohol hydroxyl and phenolic active functional groups (Figure 3-1) 
(Sutlovic et al., 2008). Although the chemical composition of humic acid is complex, it is 
easily co-extracted and co-purified with DNA. Concentrations between 0.7 and 0.33 ug/ul 
can be extracted from soil (Tebbe et al., 1993). It has been reported that trace amounts of 
humic substances can inhibit the PCR and cause false-negative results at final 
concentrations of up to 80 ng/ul (Tsai et al., 1992; Opel et al., 2010). 
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Collagen 
 Collagen is a protein that constitutes the bulk of the organic portion of bone and is 
a major component in connective tissue (Sholz et al., 1998). The presence of collagen 
may be encountered in DNA extracted from skeletal and food samples. Different collagen 
types have been identified throughout the body, however, the most abundant is type I 
(Zhou et al., 2006). All forms of collagen share the same basic structure: three 
polypeptide strands, alpha chains, coiled together to form a triple helix or “super helix,” a 
cooperative quaternary structure stabilized by numerous hydrogen bonds (Mrevlishvili et 
al., 2005). These triple helices are then coiled together and the resulting protein, often 
called tropocollagen, is the basic building block of collagen. Collagen is known to inhibit 
PCR at concentrations ranging from 15 to 100 ng/ul (Opel et al., 2010; Kim et al., 2000). 
 
Phenol 
 Phenol is a highly reactive organic compound commonly used in the 
manufacturing of plastic, as well as a precursor to pharmaceuticals and herbicides 
(Wiedbrauk et al., 1995). Phenol is a known process-introduced inhibitor most commonly 
in the Phenol Chloroform Isoamyl Alcohol (PCIA) DNA extraction step. The addition of 
phenol helps to remove proteins and lipids, leaving the nucleic acid in the aqueuous layer. 
However, traces of phenol can sometimes remain in the aqueous layer as a result of poor 
pipetting techniques and therefore inhibit the sample. The structure of phenol is a simple 
six-membered aromatic ring, bonded to a hydroxyl group. It has been reported that small 
traces of phenol is known to inactivate Taq polymerase yet functions normally in the 
presence of Tth DNA polymerase (Katcher et al., 1994). 
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Tannic acid 
 Tannic acid is a natural component of some types of wood and other plant material 
as well as a color agent found in leather (Wilson, 1997). It may be encountered in 
samples that have been exposed to leaf litter (Opel et al., 2010). Tannic acid is a 
hydrolysable plant polyphenol with anti-inflammation effects. Its complex structure 
consists of gallic acid molecules linked by glucose ester bonds. Tannic acids are 
distinguished from other plant phenolics, such as humic and fulvic acids, in terms of their 
chemical and biological properties including their ability to precipitate alkaloids, gelatin, 
and other proteins (Thoss et al., 2002). Tannic acid can inhibit a PCR reaction starting at 
a concentration of 30 ng/ul (Kontanis et al., 2006; Opel et al., 2010). 
 
Hematin 
 Hematin, the hydroxide of heme, is a metal chelating molecule found in red blood 
cells (Akane et al., 1994). It is the main oxygen carrier in blood. This heme compound, 
usually obtained from bloodstains, has been reported to sometimes co-purify with DNA 
by PCIA treatment and ethanol precipitation (Akane et al., 1994). The fundamental 
structure of hematin is a porphyrin containing a ferric ion (known as protoporphyrin IX) 
with a hydroxide ligand (Figure 3-2). Hematin is regarded as a major inhibitor of PCR 
reactions by chelating the divalent cation Mg2+, which is a required cofactor for Taq 
polymerase activity. Hematin is inhibitory to PCR at a final concentration of 0.8 uM or 
higher (Erlich, 1989; Opel et al., 2010). 
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Melanin 
 Melanin is a pigment found in human hair and skin, and is a possible inhibitor for 
telogen hair samples (Yoshii et al., 1993). Melanin is a complex and highly 
heterogeneous polymer consisting of monomeric units of dihydroxyphenylalanine 
(DOPA) and/or cysteinyl-DOPA. Its main biological function is thought to be the 
protection of epidermal cells from damage by ultraviolet irradiation. Two of the main 
melanins in the human body are eumelanin and pheomelanin. Melanin can bind to metal 
ions and a variety of small molecules. Melanin potently blocks PCR at final 
concentrations below 200 ug/ul (Eckhart et al., 2000). 
 
Bile Salts  
 One group of PCR inhibitors present in feces is bile salts (Kreader et al., 1996; 
Wilson, 1997). Bile salt is a chemical that is produced in the liver and stored in the 
gallbladder. They aid in the digestion of lipids in the small intestines and help in the 
elimination of toxins from the body. The two major bile salts in humans, cholate and 
chenodeoxycholate, are normally conjugated with either glycine or taurine (Bisschop et 
al., 2004). All bile salts consist of a steroid structure with four rings, short aliphatic side-
chain (usually four or eight carbons) terminating in a carboxylic acid, and the presence 
and orientation of different numbers of hydroxyl groups. It has been reported that more 
than 25 g/ul of bile salts (sodium glycocholate and sodium taurocholate) can inhibit 
PCR reactions. Normal adults excrete 200 to 650 mg bile salts per day, which is enough 
to reach PCR-inhibitory concentrations (Lantz et al., 1997). Concentrations between 1-10 
ug/ul inhibit the PCR reaction without the presence of additives (Kreader et al., 1996). 
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Urea 
 Urea, also called carbamide, is an organic chemical compound, which essentially is 
the waste product of the metabolism of protein in mammals. It is commonly found in 
fertilizers and is an essential raw material in the chemical industry. The molecule has two 
amine residues joined by a carbonyl functional group. Urea is the predominant inhibitory 
component of urine and was found to inhibit PCR reactions from neonatal urine samples, 
which generally contain less urea than an adolescent. It is known to inhibit at a final 
concentration of more than 50 mM (Khan et al., 1991).  
 
EDTA 
 Ehtylenediaminetetraacetic acid is a novel molecule for complexing metal ions. It is 
a chelating agent widely used to sequester di- and trivalent metal ions. It forms strong 
complexes with Mg2+, Ca2+ and Fe3+. Ehtylenediaminetetraacetic acid is a known 
inhibitor of metal dependent enzymatic reactions, and can be removed from reaction 
mixtures by ultrafiltration or alcohol precipitation of DNA. It is used in chelation therapy 
in medicine and as an additive to detergents for industrial cleaning. This common PCR 
inhibitor is a preservative and anticoagulant added to blood (Rossen et al., 1992; Al-Soud 
et al., 2000; Al-Soud et al., 2001). Inhibition by EDTA is caused by the removal of 
divalent cations from the PCR system (Seto et al., 1974). In previous PCR inhibitory 
studies, the addition of final concentrations of 0.25 mM and 1 mM EDTA inhibited the 
PCR reaction by approximately 46% without any additives present and in the presence of 
BSA or T4 gene 32 protein (gp32) respectively (Al-Soud et al., 2001; Kreader et al., 
1996).  
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Guanidine 
 Guanidine is a basic crystalline compound that is formed by the oxidation of 
guanine. It is commonly found in laboratories in the form of guanidinium salts including 
guanidinium thiocyanate (guanidinium is the conjugate acid of guanidine). Guanidinium 
thiocyanate is used primarily for the isolation of nucleic acids (Makowski et al., 1997). It 
is also used to deactivate viruses and is a general protein denaturant. It has also been 
noted that both the guanidinium cation and the thiocyanate anion have chaotropic 
properties, which means they disrupt the sturcture of macromolecules including DNA. 
 
3.3 Mechanisms of Polymerase Chain Reaction (PCR) Inhibition 
 The mechanisms associated with PCR inhibition can be hypothesized by one or 
more of three essential modes of action: Inhibitors can interfere with cell lysis during 
DNA extraction, degrade or capture nucleic acids, or inhibit DNA polymerase activity 
(Wilson, 1997). Inadequate lysing of cells can result in reduction of or failure to expose 
the target DNA, which will therefore prevent PCR amplification. Inhibitors can also 
degrade or capture nucleic acids by specific binding to either the nucleases or the DNA 
itself, depending on configuration and composition (Butler, 2005). Inhibitors act by 
binding to the active sites of the polymerase and deactivating it. The most widely used 
polymerase in PCR as previously mentioned is Taq DNA polymerase. Thermus aquaticus 
can be degraded by proteinases, denatured by phenol or detergents such as EDTA and 
inhibited by binding to the Mg2+ necessary for polymerase activity through the formation 
of chelate complexes or competing with other divalent cations. 
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 Other research studies have identified various factors affect inhibitor binding (Opel 
et al., 2010; Chung 2004).  The three potential mechanisms proposed are: binding of the 
inhibitor to the DNA template, binding of the inhibitor to the polymerase, and blocking of 
primer binding. If the inhibitor binds to DNA, there should be a reduction in the amount 
of available template and therefore changes in the CT value. If the inhibitor binds to the 
Taq polymerase, the amplicon efficiency is affected due to limiting reagent and results in 
the amplification curve not reaching its plateau. Amplicons should also be inhibited at 
roughly the same rate despite template size, primer melting temperature, and sequence, 
which would produce minimal changes in the CT value. If the inhibitor interacts with the 
primer, Taq extension is affected and there is a possibility of no available product. During 
primer extension, the inhibitor may bind to the polymerase or DNA and longer amplicons 
should be inhibited at lower concentrations than shorter amplicons. 
  
3.4 Methods to Overcome Inhibition 
 Experimentally, there are several approaches to overcome the effects of inhibitors. 
Common techniques including sample dilution, DNA purification via spin column 
filtration using Microcon® or Centricon® columns (Millipore Corporation, Bedford MA) 
and QIAQuick® and QIAamp® columns (Qiagen Inc., Valencia CA), magnetic bead 
separation using the DNA IQTM (Promega Corporation, Madison WI), and destruction of 
inhibitors that are known intercalators using sodium hydroxide (NaOH) (Yang et al., 
1998; Bourke et al., 1999).  
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 However there are other treatment methods that do not eliminate inhibition during 
DNA isolation and purification, such addition of DNA polymerase and magnesium. 
Increasing the amount of Taq polymerase and magnesium as well as the choice of DNA 
polymerase can also have a huge impact on resistance to inhibition (Butler, 2005). 
Previous research in this area has identified inhibitors that have no effect on the addition 
of Taq or magnesium – humic acid, collagen, and melanin (Opel et al., 2010).  
 Unfortunately, previous research has concluded that inhibitors still may cause 
complications for DNA samples that are highly degraded or of low template. This is 
because isolation methods for inhibitors, such as dilution, filtration or treatment with 
base, will affect recovery of these samples. For example, by diluting the inhibited sample, 
the low quantity of genomic DNA is also diluted. Inhibitors are particularly problematic 
in degraded and low copy samples, because the normal methods of removal, such as 
dilution of the sample to reduce the concentration of the inhibitor, are not applicable for 
these samples. 
 An alternate procedure to avoid PCR inhibition is to add a chaperon molecule 
such as bovine serum albumen (BSA). Bovine serum albumin is a protein used to 
stabilize the enzyme during PCR and prevents adhesion of the enzyme to reaction tubes. 
It is commonly used as pretreatment of the extracted DNA because of its stability, lack of 
effect in many biochemical reactions, and low cost (Butler, 2005). However, BSA may 
also bind to some substances, which can inhibit the PCR reaction (Satoh et al., 1998). 
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IV.  METHODOLOGY 
 
4.1 DNA Standards and Stock Soution 
 The Plexor HY Male Genomic DNA Standard, provided with the Plexor HY 
System, was used to generate standard curves ranging from 50ng/ul to 3.2pg/ul. The 
DNA Standard was also used for primer optimization. For the inhibition tests, multiple 
buccal swabs were collected from a human male individual.  The swabs were extracted 
using the PCIA with ethanol precipitation protocol (see Appendix A).  The extracts were 
combined into one stock solution, quantified using the protocol in the Plexor HY Systems 
Technical Manual (Promega, 2009 (a)), and diluted to approximately 2ng/μL 
concentration.  
 
4.2 Primer Design  
 Primers for the human RNU2 locus that amplify autosomal DNA for the Plexor HY 
System was designed using the GenBank sequence accession number K02227 (see 
Appendix B) obtained by performing a BLAST from National Center for Biotechnology 
Information (NCBI) and the online primer design programs Primer3 
(http://frodo.wi.mit.edu/primer3/input.htm) and PlexorTM Primer design Software 
(www.promega.com/plexorresources/). A primer length of 20 bp was used as a default 
and the target amplicon size range was: 150-200 bp; and target melting temperature range 
was: 58-61° C. Five sets of oligonucleotide primer pairs were designed and ordered by 
Integrated DNA Technologies (Coralville, IA). Amplification of the K562 standard DNA 
was performed for each of the five primer sets with 2ng of template DNA using the Alu-
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based qPCR protocol (see Appendix C). The primer pair with the most suitable 
parameters and amplification results was selected. The forward primer, synthesized with 
an iso-dC residue and a fluorescent label (FAM) at the 5' end, was manufactured by 
Biosearch Technologies (Novato, CA) at an amplicon size of 180 bp. 
 
4.3 Real-Time Polymerase Chain Reaction (PCR) Analysis  
 Testing of the Plexor HY System on extracted samples was performed on the 
Corbett Rotorgene 6000 Real-Time PCR System (Qiagen Inc., Valencia CA). The 
reaction components were based on the Plexor HY Systems Technical Manual (Promega, 
2009 (a)) with 1uL of nuclease-free water substituted with inhibitor. DNA (2ng/ul) was 
added to the reaction mixture before separating the mixture into aliquots and adding the 
inhibitor. The final reaction volume was 20 μL. Cycling parameters for the reactions 
were as follows: hold for 2 minutes at 95°C; 40 cycles of 95°C for 10s, then 60°C for 20s 
with data collection during the elongation/extension step.  The melt cycle was: ramp from 
65°C to 92°C, 0.5 degree for each step, with a 90 second pre-melt and 5 seconds for each 
step thereafter, with the melt data acquired to Melt A on green, orange, red, and yellow. 
All reactions were performed in triplicate. For the modified RNU2 primers, the cycling 
parameters for the reactions were as follows: hold for 3 minutes at 95°C; 45 cycles of 
95°C for 10s, 60°C for 20s, 72°C for 20s with data collection during the extension step.  
The melt cycle was: ramp from 65°C to 92°C, 0.5 degree for each step, with a 90 second 
pre-melt and 5 seconds for each step thereafter, with the melt data acquired to Melt A on 
green. 
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4.4 Inhibitor Preparations  
 The inhibitor stock solutions were prepared as follows: calcium hydrogen 
phosphate (Aldrich, Milwaukee, WI), 100 mM in 0.5 N hydrochloric acid 
(FisherScientific); humic acid (Alfa Aesar, Ward Hill, MA), 1 mg/mL in water; collagen 
(from calf skin) (Sigma), 1 mg/mL in 0.1 N acetic acid (Fisher); phenol solution (Sigma), 
100 mM in water; tannic acid (Sigma), 1 mg/mL in water; hematin (ICN Biomedicals, 
Aurora, OH), 100 mM in 0.1 N sodium hydroxide (Fisher Scientific); melanin (Sigma), 
1mg/mL in 0.5 N ammonium hydroxide (Fisher Scientific); Urea (FisherScientific), 10M 
in water; Bile salts (sodium cholate plus deoxycholate) (Fluka), 100 mg/ml in water; 
EDTA (Fluka), 0.5 M in water; Guanidinium thiocyanate (Sigma), 100 mg/ml in water. 
All subsequent dilutions were prepared with water. These inhibitors were added to 
samples prior to quantification and STR analyses.  
 
4.5 Inhibitor Concentrations  
 A range of concentrations was tested to determine at which inhibitor concentration 
a change in the signal output would be observed.  The starting concentrations were based 
on previous work with these inhibitors (Opel et al., 2010) and information on their 
chemical properties. The qPCR tests were conducted using Plexor HY multiplex primers 
(Promega, 2009 (a)) and designed RNU2 primer. The ranges of concentrations for each 
inhibitor are presented in Table 4-1. 
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4.6 Data Analysis   
 Following data collection on the real-time instrument, raw data were exported from 
the instrument software and imported into the Plexor Analysis Software version 1.5.4.18 
(Promega Corporation, Madison WI). The software generated the amplification and melt 
curves, cycle threshold (CT), product melt temperature (Tm), standard curve and unknown 
sample quantification data. The PCR inhibitory effects on qPCR amplification were 
identified by amplification efficiency, CT values, and changes in the melt curves. 
 
Table 4-1: Final inhibitor concentrations for the 20 μL reaction mix.  
 
INHIBITOR SOURCE CONCENTRATIONS 
Calcium  Milk, bone 0, 0.5, 1. 1.5, 2, 2.5 mM 
Humic acid Soils 0, 5, 10, 15, 20, 25, 30 ng/uL 
Humic acid* Soils 0, 1, 2, 3, 4, 5 ng/ul 
Collagen Bone 0, 25, 37.5, 50, 62.5, 75, 87.5, 100 ng/uL 
Phenol Organic extraction 0, 33, 66, 83, 100, 116, 133 ug/uL 
Tannic acid Plant material, leather 0, 3.75, 7.5, 11.25, 15, 18.75, 22.5 ng/uL 
Tannic acid* Plant material, leather 0, 1, 2, 3, 4, 5, 6, 7 ng/ul 
Hematin Blood 0, 15, 30, 45, 60, 75, 90, 105 uM 
Melanin Hair, tissue 0, 10, 20, 30, 40, 50, 60 ug/uL 
Bile Salts Feces 0, 0.25, 0.5, 0.75, 1, 1.25, 1.5 ug/uL 
Urea Urine 0, 200, 400, 600, 800, 1000, 1200 mM   
EDTA Blood thinner 0, 0.4, 0.8, 1.2, 1.6, 2, 2.4 mM  
Guanidinium Guanidinium salts 0, 1.5, 3, 4.5, 6, 7.5 9 ug/uL 
* Concentrations without BSA  
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Amplification Efficiency 
 The efficiency reveals the dynamics of the PCR reaction for each sample, which 
includes reaction components, potential presence of inhibitors and cycling parameters. A 
more efficient amplification will generate more products with fewer cycles. The 
individual PCR efficiency is expressed as a numerical value (between 1 and 2) and is 
calculated from slope of the amplification curve in the exponential phase (E = 10slope)  
(Ruijter et al., 2009). An ideal PCR efficiency is 100% or E=2, which means that the 
amount of amplicon has doubled; therefore E=1 means that there is no amplification. For 
this study, low efficiency values suggested that inhibition had reduced the amplification. 
Efficiency values close to 1 showed no amplification. Efficiencies were obtained by 
exporting the raw Excel data from the Real-Time PCR System and importing into 
LinRegPCR (Ruijter et al., 2009), a program that enables more reliable identification of 
efficiency over comparable approaches (Kontanis et al., 2006). 
 
Cycle threshold (CT) values  
 Cycle threshold (CT) values are inversely proportional to the log of the initial 
template DNA concentration. As a result, a higher CT value usually corresponds to a 
lower amount of template DNA. For this purpose, increasing CT values were identified as 
the inhibitor binding to the DNA, as such binding will reduce the amount of template 
available for amplification. Wider ranges in CT values indicated more binding likewise, 
smaller ranges corresponded to less interaction between DNA and inhibitor. The Plexor 
Analysis Software amplification threshold accounts for noise levels and by default is set 
at 10 standard deviations below the mean baseline fluorescence (Promega, 2009 (a)). 
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Melt Curve Changes 
 The shape and shift in the melt curve is as a result of varying Tm, the reduction in 
DNA concentration, nonspecific amplification products and other effects such as 
inhibitor binding. For the purpose of this inhibition study, changes in the melt curves 
indicated that the DNA is melting at different temperature due to the structure and mode 
of action of the inhibitor as it interferes with the DNA. As a result, inhibitors that bind 
DNA should produce shifts in the melt curves while those affecting the Taq primarily do 
not.  
 
4.7 Short Tandem Repeat (STR) Analysis 
 DNA (0.5ng) was added to a 25 uL reaction and amplified as described in the 
Powerplex16 System (Promega, 2008) and Powerplex 16 HS System (Promega, 2009 
(b)) Technical Manuals. After amplification, samples were prepared by combining 1 ul of 
sample, 9.5 ul of Hi-DiTM formamide and 0.5 ul of Internal Lane Standard 600 (ILS600) 
per reaction. Separation and detection of STR amplification products were performed on 
an ABI Prism® 310 Genetic Analyzer (Applied Biosystems, Foster City CA) using the 
GS STR POP4 (1ml) A module. Samples were injected at 5 kV for 3 seconds with 15 kV 
separation at 60°C and a run time of 35 minutes.  Data analysis was performed using the 
GeneMapper ID Software version 4.0. Electropherograms were interpreted based on peak 
height and allele drop-out at particular loci when compared to the control with a 
minimum detection threshold of 50 RFUs. 
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IV.  RESULTS AND DISCUSSION 
 
5.1 Polymerase Chain Reaction (PCR) Inhibition 
Calcium  
 Results obtained by introducing increasing amounts of calcium into different PCR 
reaction mixtures show a decrease in the reaction efficiency, increase in CT, and no 
changes in the Tm for autosomal Y, and IPC (Figures 5-1a and b). For calcium, the CT 
values increased by a factor of 12 cycles over the concentration range, potentially 
indicating a loss of template (Figure 5-1c). However, closer examination of the 
amplification curves demonstrates that this increase in CT is mainly due to a loss in 
overall reaction efficiency, not template. The Tm of calcium at different concentrations 
did not change and was consistent at 80.4 oC (Figure 5-1d). These results are consistent 
with the analysis that the major effect of calcium is on the Taq polymerase. Error bars are 
indistinguishable as the results did not deviate across the three replicates. Potential loss of 
template concentration and reduced availability of Taq throughout the runs resulted in 
relatively low efficiencies at concentrations of 1.5mM and higher (Figure 5-1e). These 
results indicate that calcium is a possible Taq inhibitor and appears to interfere with the 
interaction between the polymerase enzyme and magnesium, which acts as a cofactor for 
the enzyme. Calcium and magnesium are both divalent cations and therefore similar in 
structure and properties, so they may compete with one another throughout the PCR run. 
Limited Taq in the PCR reaction would reduce the amplification therefore generating less 
available product and low amplification efficiencies.  
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 Previous SYBR Green results involving calcium inhibition without BSA concluded 
that the addition of Taq and magnesium to the reaction produced a slight increase in 
amplification efficiency, indicating a higher affinity for the calcium ions in PCR (Opel et 
al., 2010). Gel electrophoresis studies using lower concentrations of calcium confirm a 
significant reduction in PCR inhibition occurs if the level of magnesium in the reaction is 
increased (Bickley et al., 1996). These studies demonstrate that calcium is inhibits PCR 
through interference with the magnesium cofactor of the Taq enzyme. 
 
Humic Acid 
 Humic acid reduced the efficiency of the amplification at higher concentrations of 
inhibitor but did not produce a change in the melt curve for all three amplicons (Figures 
5-2a and b). An increase in CT of approximately 10 cycles occurred over the range of 
humic acid concentration (Figure 5-2c). However, unlike calcium, this was due to a 
change in apparent template concentration, as the slope of the amplification curves was 
more constant. The change in Tm that occurred with increasing concentration of humic 
acid was 0.3 °C, which is not strong evidence of DNA binding (Figure 5-2d). However, 
high efficiencies of up to 20 ng/ul of inhibitor, does support this (Figure 5-2e).  
 Effects of inhibition were also measured at an amplicon length larger than Plexor 
primers, which amplify up to 150 bp. These modified primers, based on the RNU2 
sequence of 188 bp, did not produce changes in the melt curve when the reaction was 
optimized (Figure 5-2f). However, there were significant effects on the amplification 
efficiency. It becomes clear that the effect on CT with the longer amplicons (Figure 5-2f) 
involves effective loss of template, unlike the earlier result with calcium (Figure 5-1a) or 
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Figure 5-1a: Plexor HY amplification curves plotting RFU versus cycle number for increasing calcium 
concentrations. Changes in Autosomal (top), Y Chromosomal (middle) and IPC (bottom) curves at the 
following concentrations of calcium: 0mM (red), 0.5mM (yellow), 1mM (green), 1.5mM (blue), 2mM 
(purple), 2.5mM (pink). 
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Figure 5-1b: Plexor HY melt curves plotting the rate of change of the RFU with time versus temperature 
for increasing calcium concentrations. Changes in Autosomal (top), Y Chromosomal (middle) and IPC 
(bottom) curves at the following concentrations of calcium: 0mM (red), 0.5mM (yellow), 1mM (green), 
1.5mM (blue), 2mM (purple), 2.5mM (pink). 
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Figure 5-1c: CT versus increasing concentrations of calcium inhibitor 
 
CALCIUM INHIBITION
78
79
80
81
82
83
84
85
0 0.5 1 1.5 2 2.5
[Calcium] in mM
T
m
 (
o
C
)
 
Figure 5-1d: Tm (°C) versus increasing concentrations of calcium inhibitor 
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Figure 5-1e: Efficiency versus increasing concentrations of calcium inhibitor 
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humic acid (Figure 5-2a).  The slope of the exponential curve in Figure 5-2f remains high 
over the larger range of concentrations and the increase in CT is not the result of major 
changes in slope. Previous research using SYBR Green showed a consistent increase in 
CT with increasing concentrations of humic acid and little to no changes in efficiency 
(Opel et al., 2010).  Large changes in the melt curves with primer sets of 200 and 300 bp 
were also seen. When BSA was eliminated from the Plexor reaction, the major change 
was in the quality of the amplification curve. However no significant changes occurred in 
Tm (Figures 5-2g and h). Humic acid is a relatively large inhibitor and could be a possible 
DNA intercalator or groove binder due to its flat planar system throughout the molecule 
as well as its size, which accommodates wrapping around the DNA (Zipper et al., 2003). 
An inhibitor of that size may not bind to very short amplicon lengths (<200 bp), which 
explains the relative lack of melt curve effects. 
 For the SYBR Green results, humic acid may be competing with the dye as an 
intercalator, which produced those distinct changes in the melt curve (Opel et al., 2010). 
It was verified as a DNA inhibitor when additional Taq or magnesium did not improve 
amplification. Additional SYBR Green and TaqMan studies confirm humic acid binding 
to DNA (Tebbe et al., 1993; Sutlovic et al., 2008). The lack of major effects on the melt 
curve with Plexor may be more a function of the different checmistries in the two 
qPCRassays. SYBR green binds throughout the entire length of the double helix while 
Plexor is only measured at the distal end of the molecule. Unlike other qPCR assays, 
Plexor did not interfere or bind the dsDNA, which could be a possible reason why there 
were no effects observed. Another SYBR Green study using crude soil samples identified 
Taq as a typical inhibitor in the presence of 1ng or less (Kermekchiev et al., 2009).  
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Figure 5-2a: Plexor HY amplification curves plotting RFU versus cycle number for increasing humic acid 
concentrations. Changes in Autosomal (top), Y Chromosomal (middle) and IPC (bottom) curves at the 
following concentrations of humic acid: 0ng/uL (red), 5ng/uL (orange), 100ng/uL (yellow), 15ng/uL 
(green), 20ng/uL (blue), 25ng/uL (purple), 30ng/uL (pink). 
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Figure 5-2b: Plexor HY melt curves plotting the rate of change of the RFU with time versus temperature 
for increasing humic acid concentrations. Changes in Autosomal (top), Y Chromosomal (middle) and IPC 
(bottom) curves at the following concentrations of humic acid: 0ng/uL (red), 5ng/uL (orange), 100ng/uL 
(yellow), 15ng/uL (green), 20ng/uL (blue), 25ng/uL (purple), 30ng/uL (pink). 
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Figure 5-2c: CT versus increasing concentrations of humic acid inhibitor 
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Figure 5-2d: Tm (°C) versus increasing concentrations of humic acid inhibitor 
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Figure 5-2e: Efficiency versus increasing concentrations of humic acid inhibitor 
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Figure 5-2f: Plexor HY amplification and melt curves plotting RFU versus cycle number for increasing 
humic acid concentrations for modified RNU2 sequence. Changes in Autosomal amplification (top) and 
melt (bottom) curves at the following concentrations of humic acid: 0ng/uL, 100ng/uL, 200ng/uL, 
300ng/uL, 400ng/uL, 50ng/uL, 600ng/uL. 
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Figure 5-2g: Plexor HY amplification curves plotting RFU versus cycle number for increasing humic acid 
concentrations without BSA. Changes in Autosomal (top), Y Chromosomal (middle) and IPC (bottom) 
curves at the following concentrations of humic acid: 0ng/uL, 1ng/uL, 2ng/uL, 3ng/uL, 4ng/uL, 5ng/uL. 
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Figure 5-2h: Plexor HY melt curves plotting the rate of change of the RFU with time versus temperature 
for increasing humic acid concentrations without BSA. Changes in Autosomal (top), Y Chromosomal 
(middle) and IPC (bottom) curves at the following concentrations of humic acid: 0ng/uL, 1ng/uL, 2ng/uL, 
3ng/uL, 4ng/uL, 5ng/uL. 
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Collagen 
 Collagen reduced the amplification efficiency, produced a slight shift in CT at 
higher concentrations, and gave a change in the melt curve for all amplicons (Figures 5-
3a and b). A CT increase of 4 cycles over the range of inhibitor concentrations along with 
a gradual change in slope of the amplification curve suggests an effect on amplification 
efficiency more than the blocking of available template (Figure 5-3c). There was an 
increase in Tm of approximately 5 oC with 1 oC for the higher concentrations (Figure 5-
3d). Relatively high amplification efficiencies were calculated for smaller concentrations 
of collagen up to 62.5 ng/ul (Figure 5-3e). Interestingly the effect of the collagen on the 
IPC was minimal except at the highest levels of inhibitor. This is a strong indicator of a 
sequence specific effect and is a troubling result because the IPC is more commonly used 
to detect PCR inhibition. Clearly for collagen inhibition, this strategy would fail at mid 
levels of the inhibitor. 
 The Tm increased as inhibitor concentration increased, which signifies that 
collagen is prevents denaturing of the dsDNA and may be interfering through hydrogen 
bonding. In aqueous solution, a collagen-DNA aggregate forms and this interaction leads 
to the destruction of the collagen triple helix and stabilization of the DNA double helix 
structure (Mrevlishvili et al., 2005). Collagen could be a possible groove binder due to its 
triple helix structure and may allow wrapping throughout the DNA molecule. It is also a 
peptide and therefore susceptible to hydrogen bonding. These results suggest that 
collagen binds DNA as well as inhibits Taq, an effect concordant with previous SYBR 
green results. Plexor results tend to show the presence of both effects on Taq and on the 
DNA template. The results of Opel et al. showed that additional Taq and magnesium did 
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Figure 5-3a: Plexor HY amplification curves plotting RFU versus cycle number for increasing collagen 
concentrations. Changes in Autosomal (top), Y Chromosomal (middle) and IPC (bottom) curves at the 
following concentrations of collagen: 0ng/uL (red), 25ng/uL (orange), 37.5ng/uL (yellow), 50ng/uL 
(green), 62.5ng/uL (blue), 75ng/uL (purple), 87.5ng/uL (pink), 100ng/uL (black). 
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Figure 5-3b: Plexor HY melt curves plotting the rate of change of the RFU with time versus temperature 
for increasing collagen concentrations. Changes in Autosomal (top), Y Chromosomal (middle) and IPC 
(bottom) curves at the following concentrations of collagen: 0ng/uL (red), 25ng/uL (orange), 37.5ng/uL 
(yellow), 50ng/uL (green), 62.5ng/uL (blue), 75ng/uL (purple), 87.5ng/uL (pink), 100ng/uL (black). 
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Figure 5-3c: CT versus increasing concentrations of collagen inhibitor 
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Figure 5-3d: Tm (°C) versus increasing concentrations of collagen inhibitor 
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Figure 5-3e: Efficiency versus increasing concentrations of collagen inhibitor 
 54
not appear to improve amplification of inhibited samples indicating that the mechanism 
of inhibition is not a result of binding or interference with magnesium. However, the shift 
in Tm produced by collagen with SYBR green is opposite to that with Plexor (Opel et al., 
2010). These differences could again be due to the interference of SYBR green binding. 
Interestingly, other research on collagen inhibition has stated that Taq polymerase had 
relatively low sensitivity to collagen (Kim et al., 2000).   
 
Phenol 
 Phenol showed a reduction in efficiency, a shift in CT, and melt curve results that 
were contrary to that of collagen for all amplicons (Figures 5-4a and b). Phenol results 
were similar to collagen in some respect – it produced a minimal CT shift of 4 cycles, and 
a gradual decrease in slope of the amplification curve.  This suggests Taq inhibition more 
than DNA binding effects just as in collagen (Figure 5-4c). However, the Tm decreased 
by approximately 3 oC as inhibitor concentration increased, also indicating DNA binding 
effects (Figure 5-3d). There was a gradual reduction in amplification efficiecny as phenol 
concentration increased – an indication Taq inhibition (Figure 5-3e). 
 Like collagen, phenol exhibits both the effects of the inhibitor binding to the 
polymerase and DNA. Whereas Taq polymerase slowly deactivates and produces less 
amplified product, DNA binding to phenol results in a decrease in melting temperature, 
which produces weakening of the hydrogen bonds between bases and enhances 
denaturation. Although phenol is a protein denaturant, it may still promote unzipping of 
DNA through hydrogen bonding to ssDNA (Goldar et al., 2004). Since phenol is the 
simplest aromatic structure, it may not intercalate but slide in and out between bases,  
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Figure 5-4a: Plexor HY amplification curves plotting RFU versus cycle number for increasing phenol 
concentrations. Changes in Autosomal (top), Y Chromosomal (middle) and IPC (bottom) curves at the 
following concentrations of phenol: 0ug/uL (red), 33ug/uL (orange), 66ug/uL (yellow), 83ug/uL (green), 
100ug/uL (blue), 116ug/uL (purple), 133ug/uL (pink). 
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Figure 5-4b: Plexor HY melt curves plotting the rate of change of the RFU with time versus temperature 
for increasing phenol concentrations. Changes in Autosomal (top), Y Chromosomal (middle) and IPC 
(bottom) curves at the following concentrations of phenol: 0ug/uL (red), 33ug/uL (orange), 66ug/uL 
(yellow), 83ug/uL (green), 100ug/uL (blue), 116ug/uL (purple), 133ug/uL (pink). 
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Figure 5-4c: CT versus increasing concentrations of phenol inhibitor 
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Figure 5-4d: Tm in °C versus increasing concentrations of phenol inhibitor 
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Figure 5-4e: Efficiency versus increasing concentrations of phenol inhibitor 
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interfering with the sugar phosphate backbone. In traditional PCR followed by gel 
electrophoresis it is known that traces of phenol can completely inactivate the Taq 
polymerase (Katcher et al., 1994); however phenol is also known for direct DNA 
inhibition (Wiedbrauk et al., 1995). 
 
Tannic acid 
 Tannic acid produced a CT shift and a reduction of efficiency at higher 
concentrations of inhibitor for all amplicons (Figures 5-5a and b). The slope of the 
amplification curves was gradual and showed a minimal change in CT that was primarily 
an effect of changes in slope (Figure 5-5c), In addition there was an insignificant change 
in Tm of 0.2oC (Figure 5-5d) and a gradual reduction in efficiency as inhibitor 
concentration increased (Figure 5-5e). Tannic acid was also further studied to see if 
amplicon length and absence of BSA could enhance results. The results suggest that in a 
similar fashion to humic acid, a loss of CT occurred that was not related to efficiency.  
This was particularly evident for the autosomal amplicon and less so for the others, 
indicating potential binding to the template. However there was minimal effect on the 
melt curve just like humic acid (Figures 5-5f and g). 
 Previous research using SYBR Green also showed minimal changes in the melt 
curves but no change in the slope of the PCR amplification efficiency (Opel et al., 2010). 
These effects indicate a mixed mode inhibitor with weak binding to the DNA as well as 
interactions with the polymerase. Tannic acid contains a large number of electronegative 
groups and could be chelating the magnesium, inactivating the Taq. This would explain 
Plexor results with efficiency loss. For the larger amplicons, effects indicated by Opel et  
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Figure 5-5a: Plexor HY amplification curves plotting RFU versus cycle number for increasing tannic acid 
concentrations. Changes in Autosomal (top), Y Chromosomal (middle) and IPC (bottom) curves at the 
following concentrations of tannic acid: 0ng/uL (red), 3.75ng/uL (orange), 7.5ng/uL (yellow), 
11.25ng/uL (green), 15ng/uL (blue), 18.75ng/uL (purple), 22.5ng/uL (pink). 
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Figure 5-5b: Plexor HY melt curves plotting the rate of change of the RFU with time versus temperature 
for increasing tannic acid concentrations. Changes in Autosomal (top), Y Chromosomal (middle) and IPC 
(bottom) curves at the following concentrations of tannic acid: 0ng/uL (red), 3.75ng/uL (orange), 
7.5ng/uL (yellow), 11.25ng/uL (green), 15ng/uL (blue), 18.75ng/uL (purple), 22.5ng/uL (pink). 
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Figure 5-5c: CT versus increasing concentrations of tannic acid inhibitor 
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Figure 5-5d: Line Tm (°C) versus increasing concentrations of tannic acid inhibitor 
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Figure 5-5e: Efficiency versus increasing concentrations of tannic acid inhibitor 
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Figure 5-5f: Plexor HY  amplification curves plotting RFU versus cycle number for increasing tannic acid 
concentrations without BSA. Changes in Autosomal (top), Y Chromosomal (middle) and IPC (bottom) 
curves at the following concentrations of tannic acid: 0ng/uL, 1ng/uL, 2ng/uL, 3ng/uL, 4ng/uL, 5ng/uL, 
6ng/uL, 7ng/uL. 
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Figure 5-5g: Plexor HY melt curves plotting the rate of change of the RFU with time versus temperature 
for increasing tannic acid concentrations without BSA. Changes in Autosomal (top), Y Chromosomal 
(middle) and IPC (bottom) curves at the following concentrations of tannic acid: 0ng/uL, 1ng/uL, 2ng/uL, 
3ng/uL, 4ng/uL, 5ng/uL, 6ng/uL, 7ng/uL. 
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al. are more apparent. While there are still not melt curve effects, increases in CT for IPC 
with relatively no change in slope indicates a potential loss in amplicon availability.  For 
the TaqMan probe-based assay, another hypothesis was proposed that the free phenolic 
groups in oligomeric compounds, including tannic acid and humic acid, oxidize to form 
quinones that covalently bond and inactivate the Taq (Kontanis et al., 2006). Excess Taq 
and magnesium using SBR Green improved the reaction (Opel et al., 2010) and supports 
a potential mechanism of tannic acid as a Taq inhibitor through binding magnesium.  
 
Hematin 
 Increasing concentrations of hematin produced a shift in CT that differed between 
the three amplicons. For the autosomal amplicons, the shift in CT appeared to be related 
to a loss of template, while that for the Y and IPC amplicons was more the result of a 
changes in amplification efficiencies (Figures 5-6a). A decrease in Tm was also seen, 
similar to that with phenol (Figure 5-6b). As expected, autosomal curves displayed a 
more pronounced shift in Tm, again indicating a stronger DNA binding effect with this 
amplicon. Hematin produced a CT shift of approximately 10 cycles, which suggests 
effective DNA concentration was reduced (Figure 5-6c). However, Tm decreased by 
approximately 3oC as inhibitor concentration increased (Figure 5-3d). Hematin had a 
significant reduction in efficiency at concentrations of 60 uM and higher (Figure 5-3e).  
 The porphyrin structure of hematin may allow chelation with the magnesium ions, 
producing the efficiency changes (Akane et al., 1994). However, it is unclear how DNA 
binding effects are occurring. The effects of the longer amplicons could be as a result of 
the relative size of the inhibitor. Hematin is a larger molecule than calcium, which is a 
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Figure 5-6a: Plexor HY amplification curves plotting RFU versus cycle number for increasing hematin 
concentrations. Changes in Autosomal (top), Y Chromosomal (middle) and IPC (bottom) curves at the 
following concentrations of hematin: 0uM (red), 15uM (orange), 30uM (yellow), 45uM (green), 60uM 
(blue), 75uM (purple), 90uM (pink), 105mM (grey). 
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Figure 5-6b: Plexor HY melt curves plotting the rate of change of the RFU with time versus temperature 
for increasing hematin concentrations. Changes in Autosomal (top), Y Chromosomal (middle) and IPC 
(bottom) curves at the following concentrations of hematin: 0uM (red), 15uM (orange), 30uM (yellow), 
45uM (green), 60uM (blue), 75uM (purple), 90uM (pink), 105mM (grey). 
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Figure 5-6c: CT versus increasing concentrations of hematin inhibitor 
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Figure 5-6d: Tm (°C) versus increasing concentrations of hematin inhibitor 
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Figure 5-6e: Efficiency versus increasing concentrations of hematin inhibitor 
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possibly why melt curve effects were not observed with the largest amplicon length. 
 Results using SYBR Green were somewhat different than Plexor with this 
inhibitor. Minimal effects of melt curves and increases in CT indicated reversable DNA 
binding. Traditional PCR and electrophoresis results confirmed that hematin inhibits Taq 
polymerase activity (Alkane et al., 1994). Additional Taq did not reduce inhibition by 
hematin, but additional magnesium increased the effects of inhibition (Opel et al., 2010). 
Additional SYBR Green studies mentioned that hematin inhibition may cause 
modification, degradation or adsorption of a fluorescent dye (Kermekchiev et al., 2009). 
 
Melanin  
 As the concentration of melanin increased there were minimal changes in 
efficiency, a lowering of Tm and a gradual increase in CT for all amplification curves 
(Figures 5-7a and b). Changes in CT were approximately 10 cycles and were consistent 
with a loss of available template (Figure 5-7c). The Tm had a 1.5oC range and decreased 
as inhibitor concentration increased (Figure 5-7d). Melanin also showed no significant 
efficiency loss (Figure 5-7e). These results are consistent with melanin binding DNA. 
 These data are also very similar to those seen with SYBR green. In the report by 
Opel et al., there were minimal changes in the slope of the amplification curve, large 
changes in melt curves and an increase in CT with increasing melanin. Additional Taq 
and magnesium did not improve amplification for inhibited samples (Opel et al., 2010). 
Other results using traditional PCR and gel electrophoresis suggested melanin was a Taq 
inhibitor and the melanin-Taq complexes formed had a reversible effect (Eckhart et al., 
2000). In contrast, Plexor results did not show strong effects on Taq amplification.  
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Figure 5-7a: Plexor HY amplification curves plotting RFU versus cycle number for increasing melanin 
concentrations. Changes in Autosomal (top), Y Chromosomal (middle) and IPC (bottom) curves at the 
following concentrations of melanin: 0ug (red), 10ug/uL (orange), 20ug/uL (yellow), 30ug/uL (green), 
40ug/uL (blue), 50ug/uL (purple), 60ug/uL  (pink). 
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Figure 5-7b: Plexor HY melt curves plotting the rate of change of the RFU with time versus temperature 
for increasing melanin concentrations. Changes in Autosomal (top), Y Chromosomal (middle) and IPC 
(bottom) curves at the following concentrations of melanin: 0ug (red), 10ug/uL (orange), 20ug/uL (yellow), 
30ug/uL (green), 40ug/uL (blue), 50ug/uL (purple), 60ug/uL  (pink). 
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Figure 5-7c: CT versus increasing concentrations of melanin inhibitor 
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Figure 5-7d: Tm (°C) versus increasing concentrations of melanin inhibitor 
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Figure 5-7e: Efficiecny versus increasing concentrations of melanin inhibitor 
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Bile salts  
 Bile salts showed similar results to melanin – a change in the efficiency of the 
reaction and melt curve effects, and an increase in CT values for autosomal, Y and IPC 
curves (Figures 5-8a and b). There was a large CT shift of 11 cycles (Figure5-8c) with 
minimal effects on amplification curves. There was also a 0.5oC decrease in Tm (Figure 
5-8d). However, the shift in Tm was less consistent than with earlier samples with the 
largest shift occurring 0.2oC from the lowest inhibited samples. The subsequent samples 
produced a 0.1oC shift. The efficiency values of bile salts were similar to that of melanin, 
generating no significant loss of efficiency (Figure 5-8e). These changes in the slopes in 
the amplification curves are consistent with bile salts binding DNA. 
 Bile salts contain both polar and nonpolar regions and are known protein 
denaturants. Previous research indicated that, bile salts are inhibitory of Taq  (Al-Soud et 
al., 2001). However these results tend to indicate more of an effect on DNA template 
availability. Previous studies suggested that heating was efficient in reducing the PCR 
inhibitory effects of bile salts (Al-Soud et al., 2006). Al-Soud also showed that by adding 
BSA the inhibitory effects were reduced. However, results suggest possible DNA 
interference possibly through the formation of complexes between DNA and protein 
molecules making the DNA inaccessible for the polymerase. Plexor results suggest bile 
salts could be possibly affecting both, however the melt curve effects are not sufficient 
proof of this. 
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Figure 5-8a: Plexor HY amplification curves plotting RFU versus cycle number for increasing bile salts 
concentrations. Changes in Autosomal (top), Y Chromosomal (middle) and IPC (bottom) curves at the 
following concentrations of bile salts: 0ug (red), 0.25ug/uL (orange), 0.5ug/uL (yellow), 0.75ug/uL (green), 
1ug/uL (blue), 1.25ug/uL (purple), 1.5ug/uL  (pink). 
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Figure 5-8b: Plexor HY melt curves plotting the rate of change of the RFU with time versus temperature 
for increasing bile salts concentrations. Changes in Autosomal (top), Y Chromosomal (middle) and IPC 
(bottom) curves at the following concentrations of bile salts: 0ug (red), 0.25ug/uL (orange), 0.5ug/uL 
(yellow), 0.75ug/uL (green), 1ug/uL (blue), 1.25ug/uL (purple), 1.5ug/uL  (pink). 
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Figure 5-8c: CT versus increasing concentrations of bile salts inhibitor. 
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Figure 5-8d: Tm (°C) versus increasing concentrations of bile salts inhibitor 
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Figure 5-8e: Efficiency versus increasing concentrations of bile salts inhibitor 
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Urea  
 Urea showed slight increase in CT values and relative loss of relative efficiency for 
all amplicons (Figure 5-9a). The melt curve effects show loss of signal and small changes 
in Tm at longer amplicon lengths, indicating minimal DNA binding (Figure 5-9b). The CT 
shifts had a 2 cycle range, excluding the highest inhibitor concentration (1.2M) and the 
increase in CT was more related to changes in slope than loss of template (Figure 9c). The 
Tm for the control and inhibited samples varies by 1.5oC (Figure 5-9d). This shift is not 
sufficient enough to indicate specific DNA binding; however, is still a possibility. The 
shape of the slope in the amplification curves showed a loss of efficiency for samples 
inhibited with urea, especially those at higher concentrations of inhibitor (Figure 5-9e). 
This is an indication of Taq inhibition.  
 Urea is known to be a potent inhibitor of non-covalent bonding and therefore may 
act directly on the polymerase, or it may prevent primer annealing (Khan et al., 1991). 
However, primer annealing problems might be expected to produce a delay in CT 
indicating a reduction in the availability of DNA template. Other research concluded that 
heating of the PCR sample for a longer duration did not relieve inhibition 
(Behzadbehbahani et al., 1997). Plexor results would support the fact that urea shows 
mixed mode effects as Plexor results indicate it a possible DNA and Taq inhibitor. 
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Figure 5-9a: Plexor HY amplification curves plotting RFU versus cycle number for increasing urea 
concentrations. Changes in Autosomal (top), Y Chromosomal (middle) and IPC (bottom) curves at the 
following concentrations of urea: 0mM (red), 200mM (orange), 400mM (yellow), 600mM (green), 800mM 
(blue), 1000mM (purple), 1200mM (pink). 
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Figure 5-9b: Plexor HY melt curves plotting the rate of change of the RFU with time versus temperature 
for increasing urea concentrations. Changes in Autosomal (top), Y Chromosomal (middle) and IPC 
(bottom) curves at the following concentrations of urea: 0mM (red), 200mM (orange), 400mM (yellow), 
600mM (green), 800mM (blue), 1000mM (purple), 1200mM (pink). 
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Figure 5-9c: CT versus increasing concentrations of urea inhibitor 
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Figure 5-9d: Tm (°C) versus increasing concentrations of urea inhibitor 
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Figure 5-9e: Efficiency versus increasing concentrations of urea inhibitor 
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EDTA  
 Results for EDTA produced minimal changes in the efficiency of the reaction, 
significant CT shifts, and minor shifts in the melt curve (Figures 5-10a and b). A CT shift 
of approximately 10 cycles was related to loss of template and not a slope effect (Figure 
5-10c). Autosomal and Y amplification results clearly indicate DNA binding and not 
efficiency problems. There was also a significant change in Tm of 3oC (Figure 5-10d). 
Interestingly, there was no loss of fluorescent signal in the melt curves for autosomal 
amplicons. This may be a size or sequence effect. EDTA amplification curves showed 
relatively low efficiencies at concentrations of inhibitor greater than 1.6 mM (Figure 5-
10e).  
 Since EDTA is a divalent cation complexing agent, it was expected to inhibit the 
reaction by chelating magnesium ions that are necessary for the activity of DNA 
polymerase. However, there was minimal effect on the amplification efficiency thus the 
inhibition mechanism of EDTA may be related to its ability to inhibit DNA synthesis by 
taking out the counter ions, which likely drive the sugar phosphate backbone apart 
(Wiedbrauk et al., 1995).  
 
Guanidinium  
 Guanidinium showed insignificant changes in efficiency and CT for the autosomal 
results when compared to Y and IPC (Figure 5-11a). There were also and major shifts in 
the melt curve for all amplicons (Figures5-11b). Shifts in CT appeared to be more related 
to amplification efficiency than to loss of template (Figure 5-11c). Like collagen, 
guanidinium increased in Tm as inhibitor concentration increased indicating binding to  
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Figure 5-10a: Plexor HY amplification curves plotting RFU versus cycle number for increasing EDTA 
concentrations. Changes in Autosomal (top), Y Chromosomal (middle) and IPC (bottom) curves at the 
following concentrations of EDTA: 0mM (red), 0.4mM (orange), 0.8mM (yellow), 1.2mM (green), 1.6mM 
(blue), 2mM (purple), 2.4mM  (pink). 
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Plexor HY melt curves plotting the rate of change of the RFU with time versus temperature for increasing 
EDTA concentrations. Changes in Autosomal (top), Y Chromosomal (middle) and IPC (bottom) curves at 
the following concentrations of EDTA: 0mM (red), 0.4mM (orange), 0.8mM (yellow), 1.2mM (green), 
1.6mM (blue), 2mM (purple), 2.4mM  (pink). 
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Figure 5-10c: CT versus increasing concentrations of EDTA inhibitor 
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Figure 5-10d: Tm (°C) versus increasing concentrations of EDTA inhibitor 
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Figure 5-10e: Efficiency versus increasing concentrations of EDTA inhibitor 
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the DNA rather than disruption. The Tm range was approximately 3oC (Figure 5-11d).  
The amplification efficiency values for guanidinium were significantly low at 7.5 ug/ul 
(Figure 5-10e). Overall, the results indicate a mixed mode of inhibition with effects on 
Taq amplification efficiency as well as DNA binding. 
 Guanidinium is similar in structure to urea and are both denaturants; however, the 
results show opposing effects. Whereas urea is neutral at physiological pH’s, 
guanidinium is protonated and as a result could possibly be shielding the phosphates, 
keeping the structure intact instead of denaturing the DNA molecule. Previous research 
shows that higher temperatures are required to denature DNA with increasing 
concentrations of guanidinium (Huang, 1968). 
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Figure 5-11a: Plexor HY amplification curves plotting RFU versus cycle number for increasing 
guanidinium concentrations. Changes in Autosomal (top), Y Chromosomal (middle) and IPC (bottom) 
curves at the following concentrations of guanidinium: 0ug (red), 1.5ug (orange), 3ug (yellow), 4.5ug 
(green), 6ug (blue), 7.5ug (purple), 9ug (pink). 
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Figure 5-11b: Plexor HY melt curves plotting the rate of change of the RFU with time versus temperature 
for increasing guanidinium concentrations. Changes in Autosomal (top), Y Chromosomal (middle) and IPC 
(bottom) curves at the following concentrations of guanidinium: 0ug (red), 1.5ug (orange), 3ug (yellow), 
4.5ug (green), 6ug (blue), 7.5ug (purple), 9ug (pink). 
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Figure 5-11c: CT versus increasing concentrations of guanidinium inhibitor 
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Figure 5-11d: Tm (°C) versus increasing concentrations of guanidinium inhibitor 
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Figure 5-11e: Efficiency versus increasing concentrations of guanidinium inhibitor 
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5.2. Short Tandem Repeat (STR) Analysis 
 Calcium STR results showed a generic loss of larger alleles. This effect is 
commonly seen in all inhibitors because smaller loci have more reistance to inhibitor 
binding. This was also consistent with the inhibitor binding to the Taq polymerase. 
 For humic acid, the STR results produced both sequence specific and size 
dependent allele dropout, showing loss of the same loci found with calcium as well as 
Amelogenin and D3S1358. Humic acid binding DNA is a possible factor. 
 Collagen STR results showed effects on the polymerase and locus specific DNA 
binding. When compared to humic acid, collagen affected more loci. Interestingly phenol 
and EDTA produced drop-out of the same loci as collagen.Urea produced allele drop-out 
of two additional loci. These results are consistent with a mixed mode effect - inhibitor 
binding both Taq and DNA.  
 Table 5-1 shows the effects of allele drop-out at various concentrations of some of 
the previously studied inhibitors. 
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Table 5-1: STR effects on qPCR inhibitors 
 
INHIBITOR CONCENTRATION ALLELE DROP-OUT 
Calcium  1mM D6, TPOX, D18, CSF, FGA, PD, PE 
Calcium  2mM D6, TPOX, D18, CSF, FGA, PD, PE 
Humic Acid 16ng/ul AM, D3, D18, CSF, FGA, PD, PE 
Humic Acid 24ng/ul AM, D3, D18, CSF, FGA, PD, PE 
Collagen 16ng/ul AM, D3, D7, TPOX, D18, CSF, FGA, PD, PE 
Collagen 24ng/ul AM, D3, D7, TPOX, D18, CSF, FGA, PD, PE 
Phenol  3.3mg/ul AM, D3, D7, TPOX, D18, CSF, FGA, PD, PE 
Phenol  4.2mg/ul AM, D3, D7, TPOX, D18, CSF, FGA, PD, PE 
Urea  200mM AM, D3, D2, D7, D8, D16, TPOX, D18, CSF, FGA, 
PD, PE 
Urea  600mM AM, D3, D2, D7, D8, D16, TPOX, D18, CSF, FGA, 
PD, PE 
EDTA  3mM AM, D3, D16, TPOX, D18, CSF, FGA, PD, PE 
EDTA  9mM AM, D3, D16, TPOX, D18, CSF, FGA, PD, PE 
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VI. CONCLUSION   
 
 The purpose of this research is to provide the forensic community with 
information addressing the problems associated with inhibition of various source 
contaminants commonly found in crime scenes. Polymerase chain reaction inhibition can 
most easily be studied using qPCR assays with known concentrations of DNA template 
and inhibitor. These data will aid in the careful analysis of forensic samples by 
identifying binding mechanisms through changes in amplification and melt curves, as 
well as provide complementary information produced by the amplification of internal 
control sequences.  
 In analysis of inhibition by qPCR, several mechanisms have been observed using 
a variety of known PCR inhibitors that affect the reaction in at least one manner. 
Inhibitors such as calcium and tannic acid seem to interfere with the Taq polymerase 
through the magnesium cofactor. The addition of Taq or magnesium has proven to relieve 
inhibition but the extent to which this method will help has yet to be determined (Opel et 
al., 2010). For those inhibitors that bind to the DNA by intercalating or groove binding, 
the sequence of the amplicon as well as molecular structure are likely to determine the 
level of inhibition. Melanin and bile salts interfere with the DNA molecule through the 
formation of complexes. Both inhibitors have no effect on Taq addition (Opel et al., 
2010). The remaining inhibitors experienced a mixed mode effect by interfering with 
both the DNA and Taq. Although these inhibitors show similar modes of inhibiton, their 
inhibition technique may vary. Urea and guanidinium, for example, are similar in 
structure and bind to both DNA and Taq polymerase; however, one facilitates 
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denaturation and the other promotes hydrogen bonding of the complemntary base pairs, 
keeping the dsDNA in tact.  
 In commercial kits for qPCR assays, addition of BSA to the reaction mix reduces 
inhibition and is one of the few treatments that does not dilute the sample. Other 
treatments, including purification with silica based spin columns or rinsing the sample 
with NaOH result in a loss of DNA template (Chung, 2004). Purification of the sample 
with low melting temperature agarose can remove inhibitors but the DNA template is 
diluted by half (Chung, 2004). Therefore, for samples that are highly degraded or of low 
template DNA, these methods are not feasible. Knowledge of the type of inhibitor 
present, based on the qPCR data, will also help analysts select the method which would 
effectively remove the inhibitors without compromising the amount of DNA or further 
compromising the PCR reaction. Future research in this area could begin to classify 
inhibitors based on specific treatment methods. A standard protocol could therefore be 
generated and implemented based on the analysis of pretreated forensic samples. 
 The application of qPCR to detect PCR inhibition can provide useful data for 
laboratories confronted with such samples. Inhibitors such as calcium, humic acid and 
collagen affect STR amplification in different ways. Depending on the type of inhibition, 
different effects can be seen in the STR results. Sequence specific inhibition and allele 
dropout is often seen with inhibitors that bind DNA. However, allele drop-out does not 
necessarily mean inhibition, as degraded and low template samples can produce similar 
results. Detection of inhibition using STR results may not always be possible, which is 
why qPCR data and melt curve analysis can be so useful when poor results are seen. The 
identification of inhibition will also help the analyst determine the appropriate STR kits 
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for these challenged samples, such as MiniSTRs and other newer more robust STR 
multiplexes. 
 The results presented in this thesis demonstrate that melt curve analysis combined 
with qPCR can aid in the prediction of PCR inhibition. In the future, the effects of 
inhibition will continue to need to be assessed through qPCR assays and STR analysis. 
The effect of inhibitors on low copy and artificially degraded DNA should intensively be 
studied, as well as the effect of inhibition and degradation on the analysis of mixtures. 
This information, will positively impact the forensic community by providing tools and 
guidelines for the improved analysis of human DNA from compromised samples.  
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APPENDICES 
 
Appendix A 
Protocol: Buccal Swab Extraction  
 
Purpose  
To extract and purify human DNA from buccal swab samples  
 
Safety  
All laboratory safety procedures will be complied with during this procedure.    
 
Reagents  
PCR ddH2O  
Stain Extraction Buffer  
Dithiothreitol  
Proteinase K (600U)  
Phenol/Chloroform/Isoamyl Alcohol (25:24:1) (PCIA)  
5% Bleach solution  
ddH2O  
 
Supplies  
Wire cutters  
Weighing papers or boats.  
100-1000 μL pipettor  
10-1000 μL barrier pipet tips  
10-100 μL pipettor  
10-100 μL pipet tips  
0.5-10 μL pipettor  
10 μL pipet tips  
2 mL spin basket compatable tubes and spin baskets  
Microcon YM-30 spin columns   
15 mL capped conical bottom tubes  
gloves  
Kimwipes  
 
Equipment  
Temperature-controlled water bath set at 56oC  
Sample tube holder  
Microcentrifuge  
Analytical balance  
 
General  
Procedure will be used for extracting and purifying human DNA from buccal swab  
samples.  
Procedure will be used as necessary for research  
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Gloves should be worn at all times  
 
Procedure  
1. Preparation of samples  
a. Use the wire cutters to cut the end of a buccal swab.  
b. Place the cut swab in the bottom of a 2 mL tube 
c. Rinse wire cutter blades with ddH2O, bleach, and again with ddH2O between samples.  
Use a new weighing paper for each sample.  
2. Preparation of stain extraction buffer (SEB).  
Weigh out 6 mg of Dithiolthreitol (DTT) per mL of SEB to be used.  
Add DTT to filtered SEB in 15 mL tube, and mix. May be stored up to two weeks in the  
refrigerator  
3.  Add 300μL of  SEB to each swab sample and to one reagent blank  
4.  Add 2 μL of Proteinase K to each sample and to the reagent blank.  
5.  Make sure caps are secure, and spin tubes down to ensure swab is covered by                  
the SEB solution.   
6. Place tubes in tube holder, and place tube holder across water bath well so that the  
bottom of the tubes is covered by the water in the water bath  
7. Incubate samples at 56oC for 2-4 hours.  
8. Remove tubes from holder, wipe dry with Kimwipes, and spin down in 
microcentrifuge.  
9. Remove swab sample from tube and place in spin basket. Place spin basket back in  
tube, cap, and spin in microcentrifuge for 1 minute at 5000 rpm.  
10. Remove spin basket from tube and throw away.  
11.  Add 300 μL PCIA to each sample. Mix and spin at 5000 rpm from 3 minutes.  
12.  Assemble Microcon filters by placing filter cup, blue side up, into 2 mL tubes.          
Label with sample name/number.  
13. Remove aqueous (top layer) from sample tube with 100 μL pipettor and tips. Transfer 
to filter cup of Microcon (2-3 transfers).  Make sure not to remove any of the organic 
layer.  
14. Cap tubes and spin at 13000 rpm for 12 minutes.  
15. Dispose of filtrate. Add 200 μL PCR H2O to filter cup, cap tubes, and spin at 13000  
rpm for 12 minutes.  
16. Prepare collection tubes by removing caps and labeling with sample name/number.  
17. Add 60 μL PCR H2O directly to filter cup, and invert cup into collection tube. Allow  
to sit for 3-5 minutes, and spin at 5000 rpm for 2 minutes.  
18. Remove filter cup and discard. Cap tubes at store at 4oC overnight before 
quantification.  
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Appendix B 
RNU2 sequence, GenBank accession number D00269 
 
1     atcgcttctc ggccttttgg ctaagatcaa gtgtagtatc tgttcttatc agtttaatat 
61   ctgatacgtc ctctatccga ggacaatata ttaaatggat ttttggagca gggagatgga 
121 ataggagctt gctccgtcca ctccacgcat cgacctggta ttgcagtacc tccaggaacg 
181 gtgcacc 
 
Appendix C  
Protocol:  Alu-based Real-Time PCR Quantitation Method  
 
Purpose  
To quantify human DNA using Real Time PCR, Alu primers, and SYBR Green I dye.  
 
Safety  
All laboratory safety procedures will be complied with during this procedure.  SYBR  
Green Dye is a mutagen/carcinogen.  Appropriate handling procedures should be  
followed.  
 
Reagents  
SYBR Green I dye  
DMSO  
PCR ddH2O  
10* ABI Buffer I  
MgCl2 (25 mM)  
dNTPs (2.5 mM)  
Amplitaq Gold or RampTaq hot start Taq polymerase (5U/μL)  
Triton X100 (10% solution)  
Nonacetylated BSA (20 mg/mL)  
Alu primers, AluF and Alu82 R for small fragments, AluF and Alu124 for large  
fragments (100 pmol/μL)  
Quantiblot Standards (A-2ng, Calibrator 1 -0.7ng, Calibrator 2 - 0.1 ng)  
9948 Human Male DNA standard  
 
Supplies  
0.2 mL flat cap PCR tubes  
2 mL flat cap microcentrifuge tubes  
0.5-20 uL pipet tips  
10-100 uL pipet tips  
100-1000 uL pipet tips  
0.5-10 uL pipettor  
10-100 uL pipettor  
100-1000 uL pipettor  
gloves  
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Equipment  
0.5-10 uL pipettor  
10-100 uL pipettor  
100-1000 uL pipettor  
Corbett RotorGene 3000 Real Time PCR or Corbett RotorGene 6000 rtPCR  
36 sample rotor  
 
General  
Procedure will be used for preparing and quantifying extracted human genomic human  
DNA samples.  
Procedure will be used as necessary for research  
Gloves should be worn at all times  
  
Procedure  
1. Preparation of 0.5 % working solution of SYBR Green I (Molecular Probes, Eugene,  
OR)  
a. Take 1 μL of 10,000X concentrated SYBR Green I and add 199 μL of DMSO. Prepare  
aliquots for future use.  
2. Prepare DNA standards (or use Quantiblot Standard  
a. Use 9948 DNA standard, dilute to 1, 0.1, 0.05 ng/μL for LCN, or   
b. Use 9948 as 10 ng/μL and dilute to 1 ng/μL and 0.1 ng/μL for buccal swab samples  
3. Prepare DNA samples to be quantified: spin down before opening tubes.  
4. Prepare 36 flat-top tubes, label them on the cap. Of the 36, label 2 sets of standards and  
1 NTC (no template control).  
5. Prepare and vortex Alu Mix for 36 samples:  
Mix 542.0 μL PCR H2O, 84.0 μL 10X ABI Buffer I, 67.0 μL dNTPs, 50.0 μL MgCl2, 14  
μL Taq polymerase, 8.4 μL Alu Primer 1 (forward), 8.4 μL Alu Primer 2 (large) or 60  
(small) (reverse), 8.4 μL TritonX 10%, 8.4 μL SYBR green solution, 8.4 μL BSA in 2  
mL tube. Spin down before opening tube.  
6. Pipet 19 μL of Alu Mix into labeled PCR microtubes.  
7. Add DNA  
8. Add 1 μL of standard or DNA sample* to appropriate tube.   
9. Add 1 μL ddH2O to NTC tube.   
10. Vortex and mix.   
11. Remove bubbles and spin down.  
12. Turn on PC and turn on the Rotor Gene instrument  
13. Clean accessible optics with cotton Q-tip and ethanol.  
14. Place tubes on the appropriate wells of the carousel and place ring on top. Align  
carousel in the chamber. Screw in the cap with the red dot on top (3000) or snap ring in  
place (6000). Close cover.   
15. Select Alu program and click “New” (for RG 6000, or SYBRGreen1 for RG3000) 
Edit profile (if needed)  
Denature   95°C 10 minutes  
Denature   96°C 10 seconds  
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Cycles    45   
Cycling   95°C 15 s, 55°C 20 s, 72°C 20 s acquiring to   
cycling on SYBR Green   
Melt: Ramp from  72°C to 99°C  
Rising by  1°C each step  
Wait for  45 seconds on first step, then  
Wait for  5 seconds for each step afterwards  
Acquire to  Melt A on SYBR  
16. Calibrate: check “Perform Calibration Before 1st acquisition”.  
17. Start run, go to correct folder to name an experiment with 
“dateNamemethodsamples”.  
18. During run, fill the sample table: distinguish between DNA samples, no template  
control (NTC), and standards. Fill in the given concentrations in the “given  
concentration” column for standards and sample names for other sample tubes.  
19. When experiment is completed, click Analysis-Quantitation-Show.  New windows 
will appear and a box in the middle – click Cancel.  
Fill:  
    Slope Correct   ON  
   Eliminate cycles before  5   
   Threshold    default (0.03)  
   When the box comes up, click OK.  
The standard curve, fluorescence threshold cycle (Ct) and concentrations of samples will 
be calculated. The standard curve should have an efficiency and r value close to 1.00.  
You can choose to exclude those standard samples that cause give errors.    
If raw data is good but not quantitated, click on the “quantitative settings” and decrease  
the threshold to 2% (1%).  
20. Click “reports” in the upper left of the Quantitation window – Full Report - Send to  
Word and save.   
21. Click Analysis-Melt.  
Check if melting curve has two peaks (first is smaller).  
* Dilute buccal swab samples 1:10 before quantification. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
